• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·US·Consumer Cyclical·NSP
Held by 2 Gurus
Share

Insperity, Inc. Stocks

$ 52.52Last Updated 07.08.2026

Issuer Rating

4/7
Performance

Favourable

Risk

Limited

Recommendation

Hold

Market Cap

$ 2.01B

$ 52.52
Key Takeaways

Risk factor

Very vulnerable to price shocks

Data is available to registered users only
Data is available to registered users only

Profitability factor

Solid dividends

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

In Guru Portfolios

Kenneth Griffin

Portfolio Weight (%)

0.0%

Change

+0.00%

Fund

CITADEL ADVISORS LLC

Steven Cohen

Portfolio Weight (%)

0.0%

Change

+0.00%

Fund

Point72 Asset Management, L.P.

Manager
Fund
Portfolio Weight (%)
Change
Kenneth GriffinCITADEL ADVISORS LLC0.0%+0.00%
Steven CohenPoint72 Asset Management, L.P.0.0%+0.00%

Latest news

20.03.2026 16:11

Morning in New York: stock indices in a turbulent zone

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Insperity, Inc. (NSP) delivers comprehensive human resources and business solutions primarily designed to enhance the operational efficiency and performance of small and medium-sized enterprises. The company's core HR services are provided through its Workforce Optimization and Workforce Synchronization platforms. These encompass a broad spectrum of vital human resource functions, including payroll processing, employee benefits administration, workers' compensation management, adherence to government regulations, performance evaluation, and staff training and development programs. Additionally, Insperity offers Insperity Premier, a sophisticated cloud-native human capital management (HCM) platform. This platform facilitates professional employer organization (PEO) HR outsourcing, manages personnel records, addresses employer liability concerns, and caters to the specific needs of the middle market. Further expanding its service offerings, Insperity operates MarketPlace, an e-commerce portal featuring a diverse array of products and services, and Workforce Acceleration, which provides extensive human capital management and payroll services. This includes capabilities such as time and attendance tracking, performance reviews, organizational planning, recruitment support, employment screening, retirement planning, and various insurance solutions. As of December 31, 2021, Insperity maintained a substantial operational footprint, with 85 sales offices located across the United States. Founded in 1986, the company was initially known as Administaff, Inc., and officially adopted its current name, Insperity, Inc., in March 2011. Its corporate headquarters are situated in Kingwood, Texas.

Company Valuation

Fairly valued
4/7

From both historical and forecast perspectives, the stock is fairly priced compared to similar stocks. Specifically, the stock is 'expensive' on P/E, neutral on EV/EBITDA

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Neutral
4/7

The average target price of NSP is 50.1 and suggests 4.55% downside potential. Usually, this means a SELL recommendation among investment firms, or a recommendation to de

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

11.08.2026 17:25

Mid-cap biotech stocks soared on the back of successful trials of a hot flash treatment

11.08.2026 16:55

The price of gold rose above $4,400. Citadel identified a rare combination of factors driving the rise

11.08.2026 16:30

Biotech firm Sionna unexpectedly failed its drug trials and lost 90% of its value in a single day

11.08.2026 16:08

Brent crude has approached $90. An analyst warned of the risk of a price spike as early as next week

11.08.2026 15:27

Morning in New York: Stock Indices Near All-Time Highs

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026